Communications publiées lors de congrès ou colloques nationaux et internationaux (19)
18.
Duret, C., Wauthoz, N., Rosiere, R., Sebti, T., Vanderbist, F., & Amighi, K. (2013). Prophylactic Efficacy of Inhaled Itraconazole-Mannitol Dried Solid Dispersion Against Invasive Pulmonary Aspergillosis. In R. R. N. Dalby, P. R. Byron, J. Peart, J. D. Suman, P. M. Young, & D. Traini (Eds.), RDD Europe 2013 (pp. 383-388). (book 2). USA: Virginia Commonwealth University.19.
Duret, C., Wauthoz, N., Sebti, T., Vanderbist, F., & Amighi, K. (2012). Itraconazole Nanoparticle-based Dry Powders for Inhalation. In R. R. N. Dalby, P. R. Byron, J. Peart, J. D. Suman, S. J. Farr, & P. M. Young (Eds.), RDD 2012 Arizona (pp. 763-768) USA: Virginia Commonwealth University. Participations à des congrès et colloques internationaux (65)
1.
Wauthoz, N., Gevenois, P., Menchi, E., Lambot, C., Sebti, T., & Amighi, K. (2023). Evaluation of the efficacy of an innovative triparatopic anti-IL-13 VhH in a murine preclinical model of respiratory inflammation. Paper session presented at International Society For Aerosols in Medecine (2023: 26-30th August 2023: Saarbrücken).3.
Wauthoz, N., Chraibi, S., Davenne, T., Gérard, P., Rosiere, R., & Amighi, K. (2022). Evaluation of Tumour Exposure following the Administration of an Innovative Cisplatin Dry Powder for Inhalation at Different Dose Levels and Regimens. Paper session presented at Drug Delivery to the Lung (2022: 7-9th December 2022: Edinburg).4.
Menchi, E., El Khattabi, C., Denis, O., Pochet, S., Amighi, K., & Wauthoz, N. (2021). Determination of an appropriate dose ratio of a synergistic combination of long-acting bronchodilators for the maintenance treatment of asthma and COPD. Paper session presented at Drug Delivery to the Lung (32: 8-10th December 2021: Virtual).5.
Ravon, F., Menchi, E., Remmelink, M., Chraibi, S., Fontaine, V., & Wauthoz, N. (2021). In vitro and in vivo evaluations of the tolerance of a new and innovative anti-tuberculosis drug combination by inhalation. Paper session presented at Drug Delivery to the Lung (32: 8-10th December 2021: Virtual).6.
Gevenois, P., Declerck, S., De Braekeleer, K., Vander Heyden, Y., Sebti, T., Amighi, K., & Wauthoz, N. (2021). Optimization of IgG dry powder for inhalation (DPI) formulation stability based on polyol-sugar mixtures using a rational Design of experiment (DoE). Poster présenté à la conférence Pharmaceutics, Biopharmaceutis and Pharmaceutical Technology (12th: 11-14th May 2021: Digital).7.
Chraibi, S., Rosiere, R., De Prez, E., Langer, I., Nortier, J., Amighi, K., & Wauthoz, N. (2021). Evaluation of pulmonary and renal tolerance on mice of a cisplatin-based dry powder for inhalation to treat lung cancer. Poster présenté à la conférence Pharmaceutics, Biopharmaceutis and Pharmaceutical Technology (12th: 11-14th May 2021: Digital).9.
Chraibi, S., De Prez, E., Rosiere, R., Touzani, F., Antoine, M.-H., Wauthoz, N., Amighi, K., & Nortier, J. (2020). Évaluation préclinique de la tolérance rénale suite à l’administration par voie systémique et par inhalation de cisplatine dans un modèle murin de cancer pulmonaire. Paper session presented at congrès de la société francophone de néphrologie, dialyse et transplantation (SFNDT) (5ème: 07/10/2020-08/10/2020: Digital).10.
Chraibi, S., Rosiere, R., Larbanoix, L., Laurent, S., De Prez, E., Nortier, J., Amighi, K., & Wauthoz, N. (2020). Optimization of Cisplatin-based Regimens Combining Pulmonary and Intravenous Routes for Lung Cancer Therapy. Poster présenté à la conférence Respiratory Drug Delivery 2020 (26/04/2020-30/06/2020).